The authors reply
Kidney Int
.
2023 Oct;104(4):856-857.
doi: 10.1016/j.kint.2023.07.009.
Authors
Fernanda Florez-Barros
1
,
Siobhan Bearder
1
,
Bengt Kull
2
,
Adrian Freeman
2
,
Attila Mócsai
3
,
Michael G Robson
4
Affiliations
1
School of Immunology and Microbial Sciences, King's College London, UK.
2
AstraZeneca, Cambridge, UK.
3
Department of Physiology, Semmelweis University, School of Medicine, Budapest, Hungary.
4
School of Immunology and Microbial Sciences, King's College London, UK. Electronic address: Michael.robson@kcl.ac.uk.
PMID:
37739616
DOI:
10.1016/j.kint.2023.07.009
No abstract available
Publication types
Letter
Comment